Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Maintenance After Stem Cell Transplant in Multiple Myeloma
NCT00084747Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jun 2004
- Primary completion
- Jan 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jun 2004; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00084747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084747.